Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias

Journal of the American College of Cardiology

Volumn 34, Issue 4, 1999, Pages 1090-1095

  Domanski, Michael J ^a   Sakseena, Sanjeev ^b   Epstein, Andrew E ^c   Hallstrom, Alfred P ^d   Brodsky, Michael A ^e   Kim, Soo ^f   Lancaster, Scott ^d   Schron, Eleanor ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SOTALOL; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STROKE VOLUME; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 0033212981     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00327-7     Document Type: Article

References (17)

1. Cobb L., Baum R., Alvarez H. III, Shaffer W. Resuscitation from out-of-hospital ventricular fibrillation 4 years follow-up . Circulation. 52:(Suppl III):1975;III-223-III-35.
2. Goldstein S., Landis J., Leighton R., et al. Predictive survival models for resuscitated victims of out-of-hospital cardiac arrest with coronary heart disease. Circulation. 71:1985;873-880.
3. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
4. Uretsky B., Sheahan G. Primary prevention of sudden cardiac death in heart failure will the result be shocking? J Am Coll Cardiol. 30:1997;1589-1597.
5. Sakseena S., Madan N., Lewis C. Implantable cardioverter-defbrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis. 38:1996;445-454.
6. Antiarrhythmics Versus Implantable Defibrillators (AVID) - rationale, design, and methods. Am J Cardiol. 75:1995;470-475.
7. Cairns J., Connolly S., Roberts R., Gent M. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations. Lancet. 349:1997;675-682.
8. Julian D., Camm A., Francis G., et al. Randomized trial of the effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction. Lancet. 349:1997;667-674.
9. Goldstein S., Brooks M., Ledingham R., et al. Association between ease of suppression of ventricular arrhythmia and survival. Circulation. 91:1995;79-83.
10. Spielman S., Schwartz S., McCarthy D., et al. Predictors of the success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia a discriminant analysis . J Am Coll Cardiol. 1:1983;401-408.
11. Meissner M., Kay H., Horowitz L., Spielman S., Greenspan A., Kutalek S. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. Am J Cardiol. 61:1988;1050-1055.
12. Myerburg R., Kessler K., Castellanos A. Sudden cardiac death epidemiology, transient risk and intervention assessment . Ann Intern Med. 119:1993;1187-1197.
13. Fogoros R., Fielder S., Elson J. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. Ann Intern Med. 107:1987;635-641.
14. Powell A., Fuchs T., Finkelstein D., et al. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation. 88:1993;1083-1092.
15. Wever E., Hauer N., van Capelle F., et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in post infarct sudden death survivors. Circulation. 91:1995;2195-2203.
16. Siebles J., Kuck H. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 127:1994;1139-1144.
17. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study). Am J Cardiol. 72:1993;280-287.